Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Quattro74on Jun 11, 2020 3:36pm
150 Views
Post# 31140088

RE:RE:RE:RE:RE:A New Cancer Treatment.

RE:RE:RE:RE:RE:A New Cancer Treatment.
Well, accoring to Laser we could see fast track very soon. I agree
does that mean TLT is 3 years away? Not when the CR data comes in ~90% + and that is probably the durable CR numbers. TLT will probably get FT and accelerated approval.

BCG will probably get taken out back and shot soon. Once that Euro vaccine is approved. 'Soon' means approx a year. Once that is out of the picture it will be just TLT's solution and the vaccine for NMIBC. Unless this new treatment gets approved very soon. Wonder how it works without BCG?

Pandora wrote:
skys1 wrote: Quattro, keep in mind that company received fast track designation 3 years ago. That means their process is at least 3 years ahead of Theralase - nothoing to sneeze at.


"Nothing to sneeze at"??

3 years ahead and where are they? Doesn't that give you a WTF thought about where we really are with TLT? Give it another 5 - 10 years?




<< Previous
Bullboard Posts
Next >>